All Stories

Roche's Genentech sticks with Orionis in 2nd molecular glue deal worth $2B

Roche's Genentech is sticking with Orionis Biosciences, handing over $105 million upfront as part of its second deal with the molecular glue biotech.

May 21, 2025 - 14:50
 0
Roche's Genentech sticks with Orionis in 2nd molecular glue deal worth $2B
Roche's Genentech is sticking with Orionis Biosciences, handing over $105 million upfront as part of its second deal with the molecular glue biotech.
Read More

Tags:

Previous Article

Moderna withdraws FDA filing for flu/COVID combination vaccine, plans resubmissi...

Next Article

Judge shuts down drugmakers’ 340B rebate plans, for now

Related Posts

De-Risking Tech Transfer: A Smarter Path to Faster, More Reliable Outsourcing Outcomes

De-Risking Tech Transfer: A Smarter Path to Faster, Mor...

May 16, 2025  0

Accropeutics' TYK2/JAK1 inhibitor hits psoriasis endpoints in Chinese biotech's first phase 2 win

Accropeutics' TYK2/JAK1 inhibitor hits psoriasis endpoi...

May 21, 2025  0

J&J, Eli Lilly join $85M financing for newly unveiled gene editing biotech Stylus

J&J, Eli Lilly join $85M financing for newly unveiled g...

May 13, 2025  0